Cardior Appoints Heart Disease and RNA Drug Development Experts to Its Scientific Advisory Board to…
HANNOVER, Germany--(BUSINESS WIRE)--Cardior Pharmaceuticals, a clinical-stage biotechnology company developing non-coding RNA (ncRNA) therapies for patients with heart disease, today announced the expansion of its Scientific…